An occasional headache, or even a long history of migraines, is not itself a symptom of dementia. The two conditions are connected statistically, though: large population studies consistently show that people with migraine carry a modestly higher risk of developing dementia later in life, on the order of 25 to 35 percent above average. That link is real but easy to misinterpret. Having migraines does not mean your brain is degenerating, and most people who get headaches will never develop dementia. The relationship is more interesting, and more complicated, than a simple cause-and-effect story.
What the Population Data Actually Show
A 2025 systematic review and meta-analysis pooling eleven cohort studies with nearly seven million participants found that migraine raised the risk of all-cause dementia by about 26 percent, Alzheimer’s disease by about 32 percent, and vascular dementia by about 28 percent.1PubMed Central. Migraine is a risk factor for dementia: a systematic review and meta-analysis of cohort studies A large Korean cohort study using national health insurance records found strikingly similar numbers, with migraine patients roughly 30 percent more likely to develop all-cause dementia than matched controls.2PubMed Central. Increased risk of all-cause, Alzheimer’s, and vascular dementia in adults with migraine in Korea: a population-based cohort study Those figures are meaningful across millions of people, but they translate into a small absolute increase for any individual. If your baseline lifetime risk of dementia is, say, 10 percent, a 30 percent relative increase brings it to about 13 percent. That is not nothing, but it is far from a foregone conclusion.
One consistent finding is that migraine with aura seems to carry a higher risk than migraine without aura. The meta-analysis noted this specifically, and it aligns with what researchers see in vascular and structural brain studies. The visual disturbances, numbness, or speech changes that define aura are thought to reflect a wave of altered electrical activity sweeping across the brain’s cortex, and that process may leave traces over decades of repeated episodes.
Why Migraine Might Affect Long-Term Brain Health
The honest answer is that nobody is sure of the exact mechanism, and it probably involves several overlapping pathways rather than one clean explanation.
One pathway involves the brain’s small blood vessels. Migraine is associated with brief episodes of abnormal blood flow, and over years those episodes may contribute to tiny areas of damage in the brain’s white matter. MRI studies of migraine patients regularly find white matter hyperintensities, which are small bright spots on brain scans that indicate areas of altered tissue. In one study of 263 migraine patients, nearly two-thirds had these spots, most commonly in the frontal lobe.3PubMed Central. The Characteristics of White Matter Hyperintensities in Patients With Migraine Another study found white matter hyperintensities in roughly 41 to 44 percent of migraine patients regardless of whether they experienced aura.4Scientific Reports. White matter hyperintensity in different migraine subtypes These spots are common in aging brains generally, so their presence in migraine patients does not prove damage, but the fact that migraine patients accumulate them earlier and sometimes more extensively is a clue that something vascular is going on.
A second pathway involves inflammation. Chronic pain of any kind acts as a sustained stressor that can dysregulate the body’s stress-hormone system and promote neuroinflammation, changes that have been linked to accelerated brain aging.5Translational Psychiatry. Chronic pain and risk of cognitive impairment: a meta-analysis of longitudinal cohort studies For people who experience frequent or chronic migraines, this inflammatory burden could accumulate over decades.
Interestingly, the vascular pathway in migraine-related dementia seems to operate differently from the typical vascular dementia story. A Korean longitudinal study found that the relative risk of vascular dementia from migraine was actually higher in patients who did not have traditional cardiovascular risk factors like high blood pressure or diabetes. That suggests migraine’s effect on blood vessels follows its own distinct biology rather than simply piling onto the usual risks for stroke and vascular damage.6PubMed Central. Association between migraine and the risk of vascular dementia: A nationwide longitudinal study in South Korea
The Brain Fog During a Migraine Is Not Dementia
If you have ever tried to think clearly during a bad migraine, you know the feeling: words do not come easily, you read the same sentence three times, your processing speed drops to a crawl. This experience is real and measurable. Research on migraine-without-aura patients found significant drops in reading speed, verbal memory, and learning during attacks, confirming what sufferers report.7PubMed. Cognitive dysfunction during migraine attacks: a study on migraine without aura The critical distinction is that this cognitive dip reverses completely once the attack ends. It reflects the brain being temporarily overwhelmed by pain processing and the neurological disruption of the migraine itself, not the progressive nerve-cell loss that defines dementia.
A large prospective study of women followed over many years found that those with migraine, including migraine with aura, did not show faster rates of cognitive decline on standardized tests compared to women without migraine history.8BMJ. Migraine and cognitive decline among women: prospective cohort study So while population-level risk is slightly elevated, tracking individual cognitive trajectories tells a more reassuring story for most migraine patients. The epidemiological link and the individual cognitive trajectory can coexist because the elevated risk plays out in a subset of people, probably influenced by factors like attack frequency, aura status, and other health conditions.
Migraine Medications and Thinking Problems
One underappreciated factor in the headache-cognition conversation is medication. Several drugs used to prevent or treat migraines can themselves cause cognitive side effects. Topiramate, a common preventive medication, is well known for producing word-finding difficulties and mental fogginess, to the point that patients sometimes call it “dopamax.” These drug-induced effects can mimic early cognitive decline and cause unnecessary alarm.
On the other end of the spectrum, people who overuse acute headache medications (taking painkillers or triptans more than 10 to 15 days per month) can develop medication-overuse headache, a chronic daily headache that worsens the very condition they are trying to treat. Research shows that patients with medication-overuse headache score lower on cognitive tests measuring executive function, attention, and spatial reasoning compared to healthy controls. The longer the disease duration and the more frequent the headache days, the worse the cognitive scores tend to be.9PubMed Central. Cognitive Function and White Matter Lesions in Medication-Overuse Headache Researchers have also pointed out that past and present medication regimens should be considered as potential confounding factors when studying any link between migraine and dementia, because the drugs themselves can cloud the picture.10PubMed Central. Migraine Pharmacological Treatment and Cognitive Impairment: Risks and Benefits
This matters practically. If you have chronic headaches and you are noticing memory problems or mental sluggishness, the cause may be medication-related and therefore reversible, not a sign of neurodegeneration. Talking to your doctor about the cognitive burden of your current headache regimen is a reasonable first step before jumping to more alarming explanations.
When Headaches and Cognitive Decline Do Appear Together
There are a handful of specific medical conditions where headache and cognitive decline genuinely occur as part of the same disease process. These are uncommon, but they are worth knowing about because they are treatable, and missing them can have serious consequences.
Cerebral amyloid angiopathy with inflammation is one such condition. It primarily affects older adults and occurs when amyloid protein builds up in the walls of brain blood vessels, triggering an inflammatory response. The classic presentation includes cognitive decline, seizures, and headaches appearing together, often progressing over weeks rather than years.11PubMed. Cerebral amyloid angiopathy associated with inflammation: A systematic review of clinical and imaging features and outcome Brain imaging typically shows areas of swelling in the white matter along with evidence of past small hemorrhages.12PubMed. Cerebral amyloid angiopathy-related inflammation: imaging findings and clinical outcome Unlike the slow, decades-long statistical link between migraine and dementia, this condition produces rapid cognitive decline that should prompt urgent medical evaluation. The good news is that it often responds to immunosuppressive treatment when caught early.
Giant cell arteritis is another condition where headache and dementia-like symptoms converge. It is an inflammatory disease of the blood vessels that mainly affects people over 50, and its hallmark symptom is a new, persistent headache, often centered around the temples. When the inflammation involves blood vessels supplying the brain, it can cause strokes that produce a stepwise pattern of cognitive loss resembling multi-infarct dementia. One case series documented patients with biopsy-proven giant cell arteritis presenting with stroke or multi-infarct dementia, with headache and elevated inflammatory markers as associated features.13Medicine. Stroke and Multi-Infarct Dementia as Presenting Symptoms of Giant Cell Arteritis Untreated, this can lead to permanent brain damage or blindness. Treated with corticosteroids, the inflammation can be controlled.
Normal pressure hydrocephalus is a third condition worth mentioning. It causes a triad of gait problems, urinary issues, and cognitive decline in older adults, and headache can be part of the picture, especially when cerebrospinal fluid pressure fluctuates.14JAMA. Idiopathic Normal Pressure Hydrocephalus: A Review This condition is particularly important to recognize because it is one of the few causes of dementia that can be reversed with surgical placement of a shunt to drain excess fluid.
New Headaches After 50 Deserve Extra Attention
The age at which headaches start matters a great deal in this conversation. If you have been getting migraines since your twenties and they continue into your fifties and sixties, the character of those headaches is familiar to you and your doctor. That is a very different situation from someone who develops a new type of headache later in life.
In older adults, headache is still most commonly caused by benign conditions like tension-type headache or migraine. But the risk of a secondary cause, meaning a headache driven by an underlying disease, is higher than in younger people.15PubMed. Diagnosis and Management of Headache in Older Adults Those secondary causes include the conditions discussed above as well as brain tumors, subdural hematomas from minor head injuries, and infections. Fewer than one in ten headaches seen in clinical practice turn out to have a secondary cause, but when “red flag” features are present, investigation is warranted.16PubMed Central. “WHICH Headache to Investigate, WHEN, and HOW?”
Red flags that clinicians look for include:
- Sudden onset: a headache that reaches maximum intensity within seconds to minutes, sometimes called a “thunderclap” headache
- New pattern after 50: any headache type you have never experienced before, especially if it is progressive
- Associated neurological symptoms: weakness on one side, vision loss, confusion, or personality changes that persist between headache episodes
- Systemic signs: fever, unexplained weight loss, or a tender, thickened artery at the temple
- Positional component: a headache that gets dramatically worse when you lie down or stand up, which can suggest pressure changes in the brain
Any of these features, particularly when combined with emerging memory problems or cognitive changes, should prompt a visit to a doctor who can order appropriate imaging or blood tests. The goal is not to frighten people who get routine headaches into unnecessary scans but to identify the small number of cases where headache is genuinely pointing to something that needs treatment.
Biomarker Clues That Researchers Are Watching
One of the more provocative recent findings involves tau protein, a molecule that accumulates in the brains of people with Alzheimer’s disease and other dementias. A cross-sectional study found that migraine patients, both those with episodic and chronic migraine, had elevated levels of tau in their blood compared to healthy controls.17PubMed Central. Serum tau protein elevation in migraine: a cross-sectional case-control study This does not mean migraine is causing Alzheimer’s-like neurodegeneration. Tau is released during many forms of neuronal stress, and a single blood measurement cannot distinguish between transient stress and the relentless accumulation that characterizes dementia. But it is one more piece of evidence that repeated migraine attacks are not entirely benign events at the cellular level, and researchers are tracking whether elevated tau in midlife migraine patients predicts anything meaningful decades later.
White matter hyperintensities, the bright MRI spots discussed earlier, are another biomarker under scrutiny. Studies have found associations between their severity in migraine patients and factors like migraine severity, attack frequency, and presence of aura.18JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH. Association between Migraine Patterns and White Matter Hyperintensities in MRI Brain: A Cross-sectional Analytical Study Whether these hyperintensities represent a stepping stone toward dementia or simply a marker of vascular irritability that never progresses to clinical significance is an open question. Many older adults without any headache history accumulate similar spots, so context matters as much as the finding itself.
Shared Risk Factors That Muddy the Picture
Part of the reason the migraine-dementia link is hard to untangle is that the two conditions share several risk factors. High blood pressure, diabetes, obesity, sleep disorders, depression, and physical inactivity all independently raise the risk of both migraine chronification and dementia. Vascular risk factors in particular are common to both conditions and may account for some of the observed association.19PubMed Central. Headache – A Window to Dementia: An Unexpected Twist When a person with poorly controlled blood pressure develops both frequent migraines and later cognitive decline, the hypertension may be driving both problems rather than the migraines causing the dementia.
Sleep disruption is a particularly tangled confounder. Poor sleep worsens migraines, and migraines disrupt sleep. Independently, chronic sleep deprivation impairs the brain’s ability to clear metabolic waste products, including the amyloid and tau proteins associated with Alzheimer’s disease. Teasing apart whether migraine, sleep loss, or both are contributing to long-term cognitive risk is something researchers are still working on.
Depression follows a similar pattern. It is more common in people with chronic migraine, and it is itself an established risk factor for dementia. Whether depression in migraine patients represents a shared neurobiological vulnerability, a consequence of living with chronic pain, or a genuinely independent risk factor is not settled. The practical takeaway is that aggressively managing these comorbid conditions, including sleep, mood, cardiovascular health, and physical activity, may do more to protect long-term brain health than worrying about the migraine-dementia statistic itself.
Tension-Type and Other Non-Migraine Headaches
Most of the research linking headaches to dementia risk has focused on migraine specifically. Tension-type headache, the most common headache worldwide, has received much less attention in this context. There is some epidemiological evidence that non-migrainous headaches share vascular risk factors with dementia, but the data are thinner and the associations weaker. If you get occasional tension headaches, the evidence does not suggest you need to worry about dementia risk any more than the general population does.
Cluster headache, a less common but extremely painful headache disorder, has barely been studied in relation to cognitive decline or dementia. The episodes are intense but relatively brief and infrequent compared to chronic migraine, so the cumulative neurological burden is likely different, though that is speculation rather than established science. The bottom line for non-migraine headache sufferers is that the statistical associations discussed in this article apply primarily to migraine and should not be generalized to every type of head pain.